Sanofi SA
(LTS:0A2V)
$
49
0 (0%)
Market Cap: 122.85 Bil
Enterprise Value: 141.18 Bil
PE Ratio: 28.19
PB Ratio: 1.63
GF Score: 87/100 
Sanofi SA at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 24, 2021 / 08:00PM GMT
Release Date Price:
$46.34
(-0.04%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
Good afternoon, everybody. Welcome to our next company session at the Global Healthcare Conference. I'm delighted to welcome Sanofi to the GHC this year. Sanofi is represented by Dietmar Berger, who is Chief Medical Officer and Global Head of Product Development at Sanofi. Dietmar, thank you so much for joining us.
Dietmar P. Berger
Sanofi - Chief Medical Officer & Global Head of Development
Thank you, Geoff. Thanks for having me.
Questions & Answers
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
So a lot going on at Sanofi. We just came out of the Capital Markets Day. Perhaps you could just give us a sense of sort of what the largest development programs now going on at Sanofi are? And just help us understand where you're allocating your resources,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers